Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Duchenne muscular dystrophy2 trials
• Pompe disease1 trial

Phase

• Phase 23 trials

Status

• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Edgewise Therapeutics, Inc.2 trials
• Shionogi1 trial

Running trials

• Recruiting

  Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

  NCT07123155· Phase 2· Shionogi· Source

  Contact: Shionogi Clinical Trials Administrator Clinical Support Help Line

• Enrolling by invitation

  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  NCT06066580· Phase 2· Edgewise Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Duchenne muscular dystrophy1 recruiting
• Pompe disease1 recruiting

Closed trials

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Edgewise Therapeutics, Inc.· Source